Market Size and Overview
Global Lactose Intolerance Market reached US$ 26.2 billion in 2025 and is expected to reach US$ 45.4 billion by 2033, growing with a CAGR of 7.1% during the forecast period 2026-2033.
The lack of capacity of a person to digest the lactose sugar found in milk or any other dairy product is recognized as lactose intolerance. Ages at which lactose intolerance can develop differ. Lactose intolerance primarily affects infants, although it can also affect children as young as 2 years old and is quite prevalent in adults. Taking a lactose-reduced diet, prebiotics, probiotics, and enzyme replacement are among treatments for lactose intolerance.
However, this may lead to a deficiency in essential vitamins and nutrients including calcium, vitamin D, and riboflavin, which are essential for human health. Some people drink lactose-free milk or milk substitutes like soy or rice milk, but these products are not a substitute for real milk. Lactose intolerance affects around 75% of people worldwide. Food manufacturers have reacted to consumer demand for lactose-free options by providing a wider selection of goods that are especially created for those who are lactose intolerance. This applies to lactose-free forms of dairy products such milk, yogurt, cheese, and even packaged goods that have dairy consumers.
Market Scope
| Metrics | Details |
| CAGR | 7.1% |
| Size Available for Years | 2023-2033 |
| Forecast Period | 2026-2033 |
| Data Availability | Value (US$) |
| Segments Covered | Type, Diagnosis, Distribution Channel and Region |
| Regions Covered | North America, Europe, Asia-Pacific, South America and Middle East & Africa |
| Fastest Growing Region | North America |
| Largest Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report Request for Sample
Market Dynamics
The Increasing of Product Launches and for the Treatment
The rise of novel product launches and product approvals by the companies, helps to boost the market growth. The new product contains the purest and most effective lactase currently on the market. Maxilact Next reduces the hydrolysis time by 25% when dosed at the same amount, making it around 25% faster than the previous most rapidly market standard used for milk processing.
With the help of Maxilact Next, lactose-free dairy manufacturers can improve capacity, optimize production, and use raw materials more effectively all without compromising the flavor of lactose-free products.
The products contain live and active cultures and are created using pasture-raised milk from small family farms in the Midwest. The new Squeezable Whole Milk Classic Sour Cream Pouch from Good Culture contains milk, cream, enzymes, and live and active cultures in addition to the other four ingredients. Thus, the increase in new product launches and product approvals drives the expansion of the market.
The Rise in Prevalence of Lactose Intolerance
The view of an increase in lactose intolerance may be influenced by changes in dietary habits, particularly in regions where dairy consumption used to be low. Those who are lactose intolerance may become more conscious of their symptoms and seek diagnosis as more people globally adopt diets high in dairy products. Therefore, increasing the prevalence of Lactose intolerance will helps to boost the market growth.
For instance, according to an article published in NLM, stated that, although it is a common condition, lactose intolerance is common in children under the age of five. Young adults and teenagers are most frequently affected by it. Approximately 65% of people worldwide are lactose intolerance. Among several ethnic and racial categories, lactose intolerance varies in prevalence. Asians, Hispanics/Latinos, and African Americans are most likely to experience it, whereas European Americans are least likely to.
Lactose non-persistence is more common in ethnic groups where lactose intolerance is more common. The primary variety is the most prevalent; it can be found in up to 70% of the world's population, although not every case occurs symptoms. In contrast, the congenital a range is incredibly uncommon (about 40 cases have been documented globally to date). Thus rise of lactose intolerance will accelerate the market growth.
The Cost of Lactose Free Products are Expensive
Any additional processes in the manufacture of a product, whether it be food or another material, will typically result in higher expenses. The majority of technologies for processing ordinary dairy milk allow for one continuous flow of processing. A continuous flow of raw milk is pumped through heated pipes and metal plates to pasteurize it. When utilizing the lactase enzyme to make lactose-free milk, it takes time for the lactase to be able to break down all of the lactose in the milk (or at least enough of it). This would increase the cost and lengthen the processing time for lactose milk. The growth of the market would be hampered by the high-priced products.
Segment Analysis
The global lactose intolerance market is segmented based on type, diagnosis, distribution channel and region.
Hydrogen Breath Test is the Only Needed for Diagnosis
Lactose intolerance can be identified objectively using the hydrogen breath test. It measures the quantity of hydrogen gas created as a result of undigested lactose, which can assist medical professionals in determining the severity of the disease. The test is simple and non-invasive. It entails consuming a lactose solution and inhaling through a device that analyzes breath for hydrogen levels. Because of this, it is a safer and more comfortable option than more intrusive procedures.
Moreover, while lactose intolerance is the emergence of symptoms as a result of this malabsorption, lactose malabsorption refers to the body's inability to digest lactose. Since not everyone with lactose malabsorption exhibits symptoms, the hydrogen breath test can help distinguish between these two diseases. Depending on the individual, lactose intolerance can range in severity. Healthcare professionals can offer individualized dietary recommendations based on the results of the hydrogen breath test, such as recommending a lactose-restricted diet or suitable lactase supplements. As a result, the test features contribute to the segment growth.
Geographical Share
Prevalence of the Diseases in the Region
Due to the high prevalence of lactose intolerance, growing demand for dairy products, and growing public awareness of the digestive and health benefits of lactose-free dairy products in countries like the United States and Canada, the North American region for lactose-free dairy is anticipated to experience healthy growth during the forecast period. Additionally, the market is being driven primarily by the top companies' novel product launches and the rising prevalence of lactose intolerance. The market is expanding largely due to the vegan lifestyle's increasing acceptance.
By Type
- Primary
- Secondary
- Congenital
- Developmental
By Diagnosis
- Hydrogen breath test
- Glucose blood test
- Stool acidity test
By Distribution Channel
- Online Companies Websites
- Offline Stores
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- Middle East and Africa
Key Developments
- March 2026: Nestlé S.A. expanded lactose-free dairy products under its global nutrition portfolio, particularly in Asia and Europe, emphasizing digestive health benefits and enzyme-treated milk innovations (as reflected in product portfolio updates).
- February 2026: Danone North America expanded its lactose-free and plant-based dairy portfolio (including Silk and So Delicious lines) across U.S. retail chains, focusing on improved digestibility and clean-label formulations targeting lactose-intolerant consumers.
- January 2026: Arla Foods scaled distribution of its lactose-free dairy range across Europe and the Middle East, supported by ongoing innovation in enzymatic lactose removal technology highlighted on its official platform.
- January 2026: Abbott Laboratories enhanced its adult nutrition portfolio (Ensure range) with improved low-lactose formulations, supported by updated digestive tolerance claims highlighted on official product pages and clinical-backed positioning.
Competitive Landscape
The major global players in the market include DSM, Kshipra Biotech Private Limited, Intoleran, MACLEODS, Merck KGaA, Johnson & Johnson Services, Inc, NOW Foods, Procter & Gamble, Chr. Hansen Holding A/S, Biofermen Private Limited and among others.
Why Purchase the Report?
- To visualize the global lactose intolerance market segmentation based on type, diagnosis, distribution channel and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of lactose intolerance market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global Lactose Intolerance market report would provide approximately 61tables, 58figures and 186 Pages.
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
